Health Insurers Remain Hungry for Deals, But Headwinds Await

Although executing mergers and acquisitions (M&A) is an important part of health insurers’ growth toolkit, industry insiders tell AIS Health, a division of MMIT, that companies could face challenges completing deals in 2024 due to factors such as high interest rates and government intervention.

The Federal Trade Commission (FTC) and Department of Justice (DOJ) last month finalized updated merger guidelines for the first time since 2020. The FTC and DOJ noted the guidelines “are not themselves legally binding, but provide transparency into the Agencies’ decision-making process.”

Law firm Morgan Lewis wrote in a Dec. 21 brief that the FTC and DOJ are “dramatically expanding the number and type of transactions that the agencies will consider presumptively unlawful,” although the authors noted that the agencies have both “lost several merger cases in the last few years.”

0 Comments
© 2024 MMIT
Tim Casey

Tim Casey

Tim has worked as a reporter and editor for more than 20 years. Before joining AIS Health in December 2021, he was a business reporter covering the commercial real estate industry’s capital markets for four years. He previously covered health care business issues for two medical publishing companies and high school, college and professional sports for the Sacramento Bee newspaper. Tim has a B.A. in Psychology from the University of Notre Dame and an M.B.A. from Georgetown University.

Related Posts

businessmen-shaking-hands
May 5

Michigan, Vermont Blues Team Up to Broaden Tech, Service Offerings

READ MORE
business-negotiations
December 15

It’s Not Goodbye, It’s See You Later: Cigna, Humana Could Resurrect Deal Talks

READ MORE
anthem-building
September 29

Amid Rising Opposition, Elevance Pauses Deal to Buy Louisiana Blues

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today